Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Gross Margin
Lepu Medical Technology Beijing Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CN |
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
20.8B CNY |
58%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
224.3B USD |
56%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.1B USD |
67%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
150.7B USD |
69%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
139.8B USD |
64%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.8B USD |
66%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.6B EUR |
38%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.3B USD |
45%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.5B USD |
79%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.4B USD |
61%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
261.7B CNY |
64%
|
Lepu Medical Technology Beijing Co Ltd
Glance View
Lepu Medical Technology Beijing Co Ltd. was born in the vibrant landscape of China's rapidly evolving healthcare industry. Established in 1999, the company has grown into a formidable player in the medical device sector. It carved its niche by focusing on cardiovascular interventions, technological innovations, and pharmaceuticals. At its core, Lepu Medical thrives on leveraging its research and development expertise to create products that cater to a broad spectrum of medical needs, particularly in the cardiovascular domain. They manufacture and distribute a wide range of medical devices which include coronary stents, pacemakers, and other related products, enabling them to secure a strong foothold in both domestic and international markets. Revenue generation for Lepu Medical is a multifaceted process that leverages the company's comprehensive vertical integration strategy. The company has strategically developed a robust portfolio not only in medical devices but also in pharmaceuticals and healthcare services. This diversified offering allows them to capture value across the entire patient care continuum—from device manufacturing and pharmaceuticals to post-operative care and services. By continually investing in innovation and expanding their reach through strategic partnerships and acquisitions, Lepu Medical ensures a consistent revenue stream, reinforcing its position within the global healthcare landscape. The company's commitment to quality and technological advancement keeps it competitive, propelling its growth across various health sectors.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Lepu Medical Technology Beijing Co Ltd's most recent financial statements, the company has Gross Margin of 58.4%.
You don't have any saved screeners yet